Brief: Instil Bio Inc - Presented Clinical Data From A Compassionate Use Program For Treatment Of Metastatic Melanoma
12/04/2021 12:37
April 12 (Reuters) - Instil Bio Inc TIL.O :
* INSTIL BIO INC - PRESENTED CLINICAL DATA FROM A
COMPASSIONATE
USE PROGRAM FOR TREATMENT OF METASTATIC MELANOMA
* INSTIL BIO INC - DATA SHOWED 67% OVERALL RESPONSE RATE AND
19%
COMPLETE RESPONSE RATE IN 21 PATIENTS
* INSTIL BIO INC - ALL COMPLETE RESPONDERS REMAINED IN
REMISSION
AT TIME OF DATA CUT-OFF
Source text for Eikon: ID:nGNXb6NCmY
Further company coverage: TIL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Instil Bio
See all newsInstil Bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Instil Bio Q2 net loss narrows on lower R&D spending, restructuring charges
Brief: Instil Bio Q2 Basic EPS USD -0.63
Instil Bio, Inc. expected to post a loss of 43 cents a share - Earnings Preview
Instil Bio Q1 net loss narrows on lower R&D expenses